Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Rivaroxaban for the Treatment of Symptomatic Isolated Distal Deep Vein Thrombosis

NCT02722447 is registered in ClinicalTrials.gov with Walter Ageno as lead sponsor.

NCT NCT02722447
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02722447 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Rivaroxaban for the Treatment of Symptomatic Isolated Distal Deep Vein Thrombosis
Lead sponsor
Walter Ageno
Phase
Phase 3
Overall status
Unknown status
Start date
January 31, 2017
Completion date
June 30, 2021
Enrollment
1,100 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

deep vein thrombosis